Clinical Trial Update: A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy Adults [Phase 3]

View source ↗

Summary

Takeda's tetravalent dengue vaccine (TDV) is in a Phase 3 trial in healthy adults, with the study currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue Fever

Drugs mentioned

• Tetravalent Dengue Vaccine (TDV) (tetravalent dengue vaccine)

Snippet

Sponsor: Takeda | Conditions: Dengue Fever | Phase 3 | Status: ACTIVE_NOT_RECRUITING